Table 3.
Secondary Outcomes by Treatment Attendance Status
| Attended Mean (95% CI) | Missed Mean (95% CI) | Comparison (95% CI)a | Attended Mean (95% CI) | Rescheduled Mean (95% CI) | Comparison (95% CI)a | |
|---|---|---|---|---|---|---|
| 7-d Outcome Period | ||||||
| Predialysis systolic blood pressure, mm Hg | 147 (147 to 148) | 151 (150 to 152) | 3.36 (2.54 to 4.18) | 147 (147 to 148) | 146 (145 to 147) | −0.76 (−1.86 to 0.35) |
| 30-d Outcome Period | ||||||
| Predialysis systolic blood pressure, mm Hg | 147 (147 to 147) | 149 (148 to 150) | 1.75 (1.02 to 2.48) | 147 (146 to 147) | 147 (146 to 147) | −0.25 (−1.25 to 0.75) |
| Hemoglobin, mg/dL | 11.0 (11.0 to 11.0) | 10.8 (10.7 to 10.8) | −0.22 (−0.26 to −0.18) | 11.0 (11.0 to 11.0) | 10.9 (10.8 to 10.9) | −0.12 (−0.17 to −0.07) |
| ESA | ||||||
| Administrations/pt-y | 95.9 (95.1 to 96.8) | 93.6 (91.8 to 95.4) | 0.98 (0.96 to 1.00) | 97.7 (96.6 to 98.8) | 95.5 (93.1 to 98.0) | 0.98 (0.95 to 1.01) |
| Dose, U/treatment | 4,418 (4,364 to 4,472) | 4,607 (4,480 to 4,734) | 188 (53 to 324) | 4,425 (4,353 to 4,497) | 4,484 (4,321 to 4,646) | 58 (−118 to 234) |
Abbreviations: CI, confidence interval; ESA, erythropoiesis stimulating agent; pt, patient.
a
Comparison for ESA administrations is incidence rate ratio; all others are mean difference. All comparisons are expressed referent to “Attended.”